Although the ransomware plague took a nosedive in terms of the victim count years ago, it’s still alive and kicking. It used to home in on any computers indiscriminately, but at some point, the malicious actors realized they could squeeze a lot more profit out of the enterprise than out of individual users. This shift made businesses the most coveted target for ransomware operators.
A new threat intelligence report on doxxing, researched by cybersecurity experts at Kivu, reveals that the majority of attacks occur in the U.S., with companies in the consumer sector being more likely to fall victim to such an attack.
FireEye's Mandiant® Security Effectiveness Report 2020 reveals data about how well organizations are protecting themselves against cyber threats and the overall effectiveness of their security infrastructure.
The new Panda Security Threat Insights Report 2020 compiled by PandaLabs – anti-malware laboratory and security operations center (SOC) –illuminates several emerging trends in the cybersecurity space.
ExecuPharm, a subsidiary of the U.S. Biopharmaceutical giant Parexel, has been hit by a ransomware attack according to a recent announcement made by the company.
Ransomware is costing businesses—in ransom, yes, but also in downtime, the cost of which is typically 23 times greater than the ransom requested. The attacks are affecting large organizations and cities including Atlanta and Baltimore. Cybercriminals aren’t just attacking end-users; MSPs are the latest on the hit list.
The COVID-19 pandemic has created an environment in which malicious cyber actors thrive. They are exploiting today’s uncertainty and anxiety through ransomware attacks, phishing campaigns, social engineering and financially-motivated scams. Although we are living in unprecedented times, the cyber threats we face and the malicious actors we defend against are not new. But the globe’s singular focus on COVID-19 may make us the proverbial fish in a barrel for bad actors.
